Low Uric Acid Ups Death Risk in Hemodialysis Patients
The 5-year survival rates was 80.7% for patients in the lowest quartile of serum uric acid at HD initiation versus 89.6% for those in the highest quartile.
The 5-year survival rates was 80.7% for patients in the lowest quartile of serum uric acid at HD initiation versus 89.6% for those in the highest quartile.
Among kidney transplant recipients who died with a functioning graft, the cause of death was reported as unknown for 64% of them.
Likelihood of stone formation increases with higher calcium oxalate and calcium phosphate relative supersaturation.
In a pilot study, investigators observed no harmful effects from etelcalcetide injection, and 5 of 10 of patients had a greater than 50% decline in PTH levels.
Study reveals 2-fold higher incidence of bacteremia among dialysis patients with low and high serum sodium levels.
Each 0.1 increase in WHR is associated with a 1.7-fold increased risk of cardiovascular death.
Patients with non-dialysis chronic kidney disease and iron deficiency anemia treated with ferric citrate experienced significant declines in FGF23 regardless of change in serum phosphorus.
Study documents occurrence of rapid correction in 44.3% of hospitalized patients.
Therapy with paricalcitol alone achieved the greatest decline in intact parathyroid hormone among hemodialysis with secondary hyperparathyroidism.
Patients with post-traumatic stress disorder had an 11% lower death risk 1 year after initiating dialysis than those without the disorder, study finds.